cp 96345 has been researched along with Granulomas in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, AM; Cook, G; Elliott, D; Mathew, RC; Metwali, A; Weinstock, JV | 1 |
| Blum, A; Elliott, D; Lynch, R; Metwali, A; Sandor, M; Weinstock, JV | 1 |
2 other study(ies) available for cp 96345 and Granulomas
| Article | Year |
|---|---|
Substance P modulates antigen-induced, IFN-gamma production in murine Schistosomiasis mansoni.
Topics: Animals; Antigens, Surface; Biphenyl Compounds; Female; Granuloma; Interferon-gamma; Interleukin-5; Lymphocyte Subsets; Membrane Glycoproteins; Mice; Mice, Inbred CBA; Receptors, Neurokinin-2; Receptors, Neurotransmitter; Schistosomiasis mansoni; Spleen; Substance P; Tachykinins; Thy-1 Antigens | 1993 |
Substance P receptor antagonist inhibits murine IgM expression in developing schistosome granulomas by blocking the terminal differentiation of intragranuloma B cells.
Topics: Animals; B-Lymphocytes; Biphenyl Compounds; CD4-Positive T-Lymphocytes; Cell Count; Cell Differentiation; Cytokines; Female; Flow Cytometry; Granuloma; Immunoglobulin M; Mice; Mice, Inbred CBA; Neurokinin-1 Receptor Antagonists; Schistosomiasis; Spleen | 1996 |